glp-1 and alzheimer's drugs failed to slow in two big clinical trials GLP-1R agonists protect against Alzheimer's

It simply passes through and is excreted

doi: 10.1158/0008-5472.CAN-20-2270 94 ColwellNLarionMGilesAJSeldomridgeANSizdahkhaniSGilbertMRet al

Alternatively, a number of clinical trials have been conducted in the recent past to examine the radiomodulating effect of selenium in general for improving the quality of life of cancer patients undergoing radiotherapy [95,96,97,98,99]

Moreover, a peptide consisting of a prostate-specific membrane antigen (PSMA) substrate linked to a membrane-disrupting amoebapore H3 peptide (GFIATLCTKVLDFGIDKLQLIEDK) was highly active against PSMA-expressing LNCaP prostate cancer cells but not against PSMA-negative PC3 prostate cancer cells 64

Great product I love it, my food noise is gone, and it was easy to inject